Article
Phenotypes and endotypes of uncontrolled severe asthma: new treatments.
Journal of investigational allergology & clinical immunology - 1 Jan 2013
Campo P, Rodríguez F, Sánchez-García S, Barranco P, Quirce S, Pérez-Francés C, Gómez-Torrijos E, Cárdenas R, Olaguibel J M, Delgado J
Abstract excerpt
Severe asthma is a heterogeneous disease that affects only 5%-10% of asthmatic patients, although it accounts for a significant percentage of the consumption of health care resources. Severe asthma is characterized by the need for treatment with high doses of inhaled corticosteroids and includes several clinical and pathophysiological phenotypes. To a large extent, this heterogeneity restricts characterization of...
Topics
- Adolescent
- Adrenal Cortex Hormones
- Adult
- Anti-Asthmatic Agents
- Anti-Bacterial Agents
- Antibodies, Monoclonal
- Asthma
- Biomarkers
- Bronchodilator Agents
- Child
- Child, Preschool